| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Can drones save lives and money? An economic evaluation of airborne delivery of automated external defibrillators
|
Röper, Johann W. A.
|
|
|
24 |
7 |
p. 1141-1150
|
artikel
|
| 2 |
Competition and collaboration in health care: reconciling the irreconcilable? Lessons from The Netherlands
|
Varkevisser, Marco
|
|
|
24 |
7 |
p. 1019-1021
|
artikel
|
| 3 |
“COVID-19 and income inequality in OECD countries:” A methodological comment
|
Stark, Oded
|
|
|
24 |
7 |
p. 1235-1237
|
artikel
|
| 4 |
COVID-19 and income inequality in OECD countries: a methodological comment—a reply
|
Wildman, John
|
|
|
24 |
7 |
p. 1239-1241
|
artikel
|
| 5 |
Does health technology assessment compromise access to pharmaceuticals?
|
Büssgen, Melanie
|
|
|
24 |
7 |
p. 1245-1248
|
artikel
|
| 6 |
Do not PIMP my nursing home ride! The impact of Potentially Inappropriate Medications Prescribing on residents’ emergency care use
|
Rapp, Thomas
|
|
|
24 |
7 |
p. 1085-1100
|
artikel
|
| 7 |
Estimating healthcare expenditures after becoming divorced or widowed using propensity score matching
|
Meulman, Iris
|
|
|
24 |
7 |
p. 1047-1060
|
artikel
|
| 8 |
Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries
|
Efthymiadou, Olina
|
|
|
24 |
7 |
p. 1023-1031
|
artikel
|
| 9 |
Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment
|
Gandjour, Afschin
|
|
|
24 |
7 |
p. 1243-1244
|
artikel
|
| 10 |
Mapping analysis to predict SF-6D utilities from health outcomes in people with focal epilepsy
|
Flint, India
|
|
|
24 |
7 |
p. 1061-1072
|
artikel
|
| 11 |
Out-of-pocket expenses of patients with inflammatory bowel disease: a comparison of patient-reported outcomes across 12 European countries
|
Holko, Przemysław
|
|
|
24 |
7 |
p. 1073-1083
|
artikel
|
| 12 |
The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease
|
Špacírová, Zuzana
|
|
|
24 |
7 |
p. 1033-1045
|
artikel
|
| 13 |
The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study
|
Cox, Ingrid A.
|
|
|
24 |
7 |
p. 1121-1139
|
artikel
|
| 14 |
The effects of an increase in the retirement age on health care costs: evidence from administrative data
|
Geyer, Johannes
|
|
|
24 |
7 |
p. 1101-1120
|
artikel
|
| 15 |
The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review
|
Meregaglia, Michela
|
|
|
24 |
7 |
p. 1151-1216
|
artikel
|
| 16 |
What if 0 is not equal to 0? Inter-personal health utilities anchoring using the largest health gains
|
Jakubczyk, Michał
|
|
|
24 |
7 |
p. 1217-1233
|
artikel
|
Tijdschrift beschrijving